The mTor inhibitor rapamycin delays xenogeneic acute graft versus host disease (aGVHD) in NOD/SCID/IL2rgnull mice (NSG): impact of regulatory T cells

Poster (Scientific congresses and symposiums)

Bruck, France; BARON, Frédéric; Dubois, Sophie et al.

2011 • Belgian Hematological Society Annual General Meeting

Permalink
https://hdl.handle.net/2268/148896

Bruck-P-BHS2011.pdf

Publisher postprint (38.52 kB)

All documents in ORBi are protected by a user license.

Disciplines :

Hematology

Author, co-author :

Bruck, France

BARON, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique

Dubois, Sophie

BRIQUET, Alexandra ; Centre Hospitalier Universitaire de Liège - CHU > Centre d'oncologie

Hannon, Muriel ; Centre Hospitalier Universitaire de Liège - CHU > Centre d'oncologie

Belle, Ludovic ; Université de Liège - ULiège > GIGA-R : Hématologie

MENTEN, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Centre d'oncologie

BEGUIN, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique

Humblet-Baron, Stéphanie

Language :

English

Title :

The mTor inhibitor rapamycin delays xenogeneic acute graft versus host disease (aGVHD) in NOD/SCID/IL2rgnull mice (NSG): impact of regulatory T cells

Publication date :

2011

Event name :

Belgian Hematological Society Annual General Meeting

Event date :

Janvier 2011

Audience :

International

Available on ORBi :

since 22 May 2013

Number of views

49 (5 by ULiège)

Number of downloads

62 (2 by ULiège)